At Shoulder Innovations, we address the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.Our team has been involved with launching many of the leading shoulder implants over the past 30 years, and the InSet Total Shoulder System is the most innovative yet.

cultivateMD is a unique, medical venture capital fund.We focus on investing in technologies that improve outcomes and reduce cost from the healthcare system.The healthcare and medical device space is a top area of focus, spending and high growth worldwide. This, of course, creates a very healthy and positive environment for strategic investors.

Genesis is an early stage investor in medical device technology. We are differentiated through our deep level of engagement in delivering value through all stages of the medical device commercialization process. This is accomplished by leveraging the time, talent, and financial resources of the Genesis Innovation Group Portfolio.

David Blue is an entrepreneurially driven healthcare executive with over 33 years of experience in the medical device industry and healthcare services companies.Mr. Blue has brought special emphasis on finding innovative technologies, attracting strong medical device talent, building strong leadership teams, as well as in fast growth for both the large Strategics as well as for many “start-up” ventures.He has served in various national senior executive leadership positions and key roles through-out a wide variety of different staged healthcare companies, with a heavy emphasis and focus on the orthopedic space. Companies include: DePuy, Tornier, Zimmer, Conventus Orthopedics, Shoulder Innovations, and Genesis Innovation Group.